HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

16.300

+1.1007.24%

Volume:5.21M

Turnover:85.20M

Market Cap:16.17B

PE:-48.05

High:16.680

Open:15.520

Low:15.520

Close:15.200

52wk High:18.750

52wk Low:3.920

Shares:992.00M

HK Float Shares:992.00M

Volume Ratio:1.30

T/O Rate:0.53%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.339

ROE:-12.77%

ROA:-12.32%

PB:7.67

PE(LYR):-48.05

PS:6057.57

Loading ...

Overview Company News Filings

HK Movers | Ascletis Pharma Stock up 8% After GIC Invests US$100M in Company, Anchoring Long-Term Capital in China's Core Innovative Drug Assets

Tiger Newspress

ASCLETIS-B Shares Surge Nearly 9% in Morning Session Following GIC's HK$781 Million Stake Increase

Tirzepatide Crowned as New "Blockbuster Drug King" with Rapid Commercial Value Release Expected for Weight Loss Medications

Ascletis Pharma (SEHK:1672) Is Up 5.4% After HK$844m Follow-On Offering And Positive Phase III Acne Data - Has The Bull Case Changed?

Simply Wall St.

After Clearing Up Acne, Sagimet Stock Rises -- Barrons.com

Ascletis (01672) Publishes Monthly Return on Securities Movements for January 2026

Bulletin Express

Ascletis Pharma Seeks HK$843 Million via Share Offering

MT Newswires Live

BRIEF-Ascletis Pharma To Place 69.3 Million Shares

ASCLETIS-B (01672) Proposes Placement of 69.256 Million Shares at Approximately 4% Discount, Targeting Net Proceeds of About HK$835.3 Million

Ascletis Pharma kündigt Privatplatzierung neuer Aktien an

Ascletis Pharma Inc - to Place 69.3 Mln Shares at HK$12.18 per Share

THOMSON REUTERS

Sagimet Biosciences Reports Positive 52-Week Phase 3 Results for Denifanstat in Moderate to Severe Acne

Assessing Ascletis Pharma (SEHK:1672) Valuation After Positive Acne Data And Denifanstat NDA Acceptance

Simply Wall St.

BRIEF-Ascletis Pharma Gets Positive Topline Results From Phase III Open-Label Study Of Denifanstat

Ascletis Pharma Inc. (1672) Announces Positive Phase III Data on Denifanstat (ASC40) for Acne Treatment

Bulletin Express

Ascletis Pharma-B (01672): First-in-Class Oral FASN Inhibitor Denifostat (ASC40) Achieves Positive Topline Results in Phase III Open-Label Acne Study

Ascletis Announces Positive Topline Results From Its Phase Iii Open-Label Study of Denifanstat (Asc40), a First-in-Class, Once-Daily Oral Fasn Inhibitor for Acne

THOMSON REUTERS

Ascletis Pharma Inc - Denifanstat (Asc40) Shows Favorable Safety in Phase Iii Study

THOMSON REUTERS

Ascletis Pharma New Drug Application for Denifanstat Accepted by China National Medical Products Administration

Ascletis Pharma Inc - Positive Topline Results From Phase Iii Open-Label Study of Denifanstat (Asc40)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01672/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"01672","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"ASCLETIS-B","latestPrice":16.3,"timestamp":1770624510002,"preClose":15.2,"halted":0,"volume":5209200,"delay":0,"changeRate":0.07236842105263168,"floatShares":992000000,"shares":992000000,"eps":-0.33926343998749414,"marketStatus":"Closed","change":1.1,"latestTime":"02-09 16:08:30","open":15.52,"high":16.68,"low":15.52,"amount":85202228,"amplitude":0.076316,"askPrice":16.3,"askSize":2000,"bidPrice":16.28,"bidSize":59000,"shortable":3,"etf":0,"ttmEps":-0.2995589876504612,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770687000000},"marketStatusCode":5,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":15.2,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":1.297056,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","floatShares":992000000,"roa":"-12.32%","roe":"-12.77%","lyrEps":-0.339263,"volumeRatio":1.297056,"shares":992000000,"dividePrice":0,"high":16.68,"amplitude":0.076316,"preClose":15.2,"low":15.52,"week52Low":3.92,"pbRate":"7.67","psRate":"6057.57","week52High":18.75,"institutionHeld":0,"latestPrice":16.3,"committee":0.934426,"eps":-0.33926343998749414,"divideRate":0,"volume":5209200,"delay":0,"ttmEps":-0.2995589876504612,"open":15.52,"prevYearClose":11.39,"prevWeekClose":15.2,"prevMonthClose":13.8,"prevQuarterClose":11.39,"fiveDayClose":12.69,"twentyDayClose":12.46,"sixtyDayClose":11.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01672\",params:#limit:5,,,undefined,":[{"date":"2025-08-15","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755221400000,"name":null,"time":"","dateTimestamp":1755187200000,"actualEps":null},{"date":"2025-03-26","symbol":"01672","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Pre-Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-30","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-25","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-21","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01672\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01672\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1749916800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01672\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01672","date":"2026-02-06","current":-54.413323,"percent":0.004878,"low":-62.492237,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"high":-3.060869,"avg":-16.332381,"sd":11.415422,"marketCap":15076489664},"quantilePoints":[{"date":"2021-02-11","current":-26.94677,"twenty":-27.163157,"median":-26.50182,"eighty":-25.840901,"marketCap":3241406900},{"date":"2021-02-19","current":-29.217648,"twenty":-27.39605,"median":-26.606395,"eighty":-25.934212,"marketCap":3516102400},{"date":"2021-02-26","current":-27.726401,"twenty":-28.252216,"median":-26.780324,"eighty":-26.051041,"marketCap":3329309460},{"date":"2021-03-05","current":-26.695247,"twenty":-28.196164,"median":-26.801757,"eighty":-26.075007,"marketCap":3197455620},{"date":"2021-03-12","current":-27.661035,"twenty":-27.925684,"median":-26.796554,"eighty":-25.934212,"marketCap":3307333820},{"date":"2021-03-19","current":-27.578315,"twenty":-28.013713,"median":-26.946171,"eighty":-26.051041,"marketCap":3296346000},{"date":"2021-03-26","current":-26.684915,"twenty":-27.992927,"median":-26.925194,"eighty":-26.075007,"marketCap":3175479980},{"date":"2021-04-01","current":-12.856888,"twenty":-27.937324,"median":-26.841361,"eighty":-25.906193,"marketCap":3186467800},{"date":"2021-04-09","current":-12.651626,"twenty":-27.902405,"median":-26.79135,"eighty":-25.749374,"marketCap":3142516520},{"date":"2021-04-16","current":-12.515766,"twenty":-27.83964,"median":-26.703111,"eighty":-25.606579,"marketCap":3120540880},{"date":"2021-04-23","current":-12.748275,"twenty":-27.761167,"median":-26.610487,"eighty":-20.3699,"marketCap":3186467800},{"date":"2021-04-30","current":-12.958615,"twenty":-27.702929,"median":-26.546385,"eighty":-12.849963,"marketCap":3252394720},{"date":"2021-05-07","current":-13.875629,"twenty":-27.671533,"median":-26.500215,"eighty":-12.917924,"marketCap":3505114580},{"date":"2021-05-14","current":-13.623513,"twenty":-27.632266,"median":-26.264893,"eighty":-13.033167,"marketCap":3439187660},{"date":"2021-05-21","current":-13.663274,"twenty":-27.599178,"median":-26.114327,"eighty":-13.140261,"marketCap":3450175480},{"date":"2021-05-28","current":-15.770587,"twenty":-27.536493,"median":-26.046286,"eighty":-13.276483,"marketCap":4021542120},{"date":"2021-06-04","current":-14.720056,"twenty":-27.44752,"median":-25.775671,"eighty":-13.355805,"marketCap":3735858800},{"date":"2021-06-11","current":-16.063352,"twenty":-27.383939,"median":-25.742295,"eighty":-13.363408,"marketCap":4076481220},{"date":"2021-06-18","current":-14.31767,"twenty":-27.321052,"median":-25.623114,"eighty":-13.37885,"marketCap":3604004960},{"date":"2021-06-25","current":-15.287624,"twenty":-27.213321,"median":-25.50862,"eighty":-13.470373,"marketCap":3845737000},{"date":"2021-07-02","current":-15.35814,"twenty":-27.20728,"median":-21.095972,"eighty":-13.623513,"marketCap":3856724820},{"date":"2021-07-09","current":-15.855335,"twenty":-27.138398,"median":-16.377335,"eighty":-13.663274,"marketCap":3977590840},{"date":"2021-07-16","current":-14.892058,"twenty":-27.096973,"median":-16.253526,"eighty":-13.686225,"marketCap":3735858800},{"date":"2021-07-23","current":-14.192621,"twenty":-26.97726,"median":-16.035624,"eighty":-13.755247,"marketCap":3560053680},{"date":"2021-07-30","current":-12.791706,"twenty":-26.94677,"median":-15.809995,"eighty":-13.432088,"marketCap":3219431260},{"date":"2021-08-06","current":-12.341273,"twenty":-26.946171,"median":-15.662682,"eighty":-13.226349,"marketCap":3098565240},{"date":"2021-08-13","current":-12.368185,"twenty":-26.904217,"median":-15.576148,"eighty":-12.99939,"marketCap":3109553060},{"date":"2021-08-20","current":-11.921226,"twenty":-26.880965,"median":-15.419458,"eighty":-12.856888,"marketCap":2988687040},{"date":"2021-08-27","current":-9.483763,"twenty":-26.801757,"median":-15.385644,"eighty":-12.791706,"marketCap":3065601780},{"date":"2021-09-03","current":-9.989583,"twenty":-26.79135,"median":-15.321348,"eighty":-12.740344,"marketCap":3230419080},{"date":"2021-09-10","current":-10.099521,"twenty":-26.758891,"median":-15.242013,"eighty":-12.683051,"marketCap":3274370360},{"date":"2021-09-17","current":-9.347674,"twenty":-26.710974,"median":-15.066642,"eighty":-12.561454,"marketCap":3021650500},{"date":"2021-09-24","current":-9.343351,"twenty":-26.698392,"median":-15.042421,"eighty":-12.475139,"marketCap":3021650500},{"date":"2021-09-30","current":-8.973563,"twenty":-26.689048,"median":-14.919568,"eighty":-12.420739,"marketCap":2911772300},{"date":"2021-10-08","current":-9.244464,"twenty":-26.640258,"median":-14.827353,"eighty":-12.337134,"marketCap":2999538360},{"date":"2021-10-15","current":-9.166534,"twenty":-26.60885,"median":-14.642735,"eighty":-12.284716,"marketCap":2976292730},{"date":"2021-10-22","current":-9.46655,"twenty":-26.590594,"median":-14.417378,"eighty":-12.067263,"marketCap":3095773440},{"date":"2021-10-29","current":-9.149748,"twenty":-26.550486,"median":-14.330599,"eighty":-10.167628,"marketCap":2984772960},{"date":"2021-11-05","current":-8.624888,"twenty":-26.516254,"median":-14.241832,"eighty":-9.980119,"marketCap":2818192610},{"date":"2021-11-12","current":-9.42017,"twenty":-26.501178,"median":-13.883402,"eighty":-9.642783,"marketCap":3090742560},{"date":"2021-11-19","current":-9.993809,"twenty":-26.445097,"median":-13.875629,"eighty":-9.639623,"marketCap":3274313120},{"date":"2021-11-26","current":-9.93865,"twenty":-26.337858,"median":-13.67475,"eighty":-9.647662,"marketCap":3257283040},{"date":"2021-12-03","current":-10.40565,"twenty":-26.272117,"median":-13.432088,"eighty":-9.665551,"marketCap":3416642270},{"date":"2021-12-10","current":-10.070825,"twenty":-26.190811,"median":-13.356835,"eighty":-9.665551,"marketCap":3312350560},{"date":"2021-12-17","current":-9.235444,"twenty":-26.118235,"median":-13.082869,"eighty":-9.631582,"marketCap":3035489310},{"date":"2021-12-24","current":-9.813413,"twenty":-26.084896,"median":-12.999709,"eighty":-9.575593,"marketCap":3228535530},{"date":"2021-12-31","current":-10.844012,"twenty":-26.065307,"median":-12.934788,"eighty":-9.578506,"marketCap":3575354860},{"date":"2022-01-07","current":-11.844839,"twenty":-13.746537,"median":-11.844839,"eighty":-10.061407,"marketCap":3890507720},{"date":"2022-01-14","current":-13.898995,"twenty":-13.746537,"median":-12.309572,"eighty":-10.552334,"marketCap":4575150140},{"date":"2022-01-21","current":-16.436478,"twenty":-16.916833,"median":-13.314768,"eighty":-11.444508,"marketCap":5422802660},{"date":"2022-01-28","current":-12.515763,"twenty":-15.891088,"median":-13.294428,"eighty":-11.905461,"marketCap":4118721860},{"date":"2022-02-04","current":-12.918373,"twenty":-15.527494,"median":-13.172133,"eighty":-11.945875,"marketCap":4249129940},{"date":"2022-02-11","current":-13.749623,"twenty":-15.527494,"median":-13.643555,"eighty":-12.107031,"marketCap":4531680780},{"date":"2022-02-18","current":-14.699583,"twenty":-15.230713,"median":-13.762166,"eighty":-12.512113,"marketCap":4868568320},{"date":"2022-02-25","current":-14.401585,"twenty":-15.230713,"median":-13.898995,"eighty":-12.515763,"marketCap":4781629600},{"date":"2022-03-04","current":-15.050437,"twenty":-15.15343,"median":-14.35444,"eighty":-12.745602,"marketCap":4998976400},{"date":"2022-03-11","current":-11.829182,"twenty":-15.076137,"median":-14.197144,"eighty":-12.515763,"marketCap":3923109740},{"date":"2022-03-18","current":-18.160245,"twenty":-15.15343,"median":-14.130354,"eighty":-12.512113,"marketCap":5998771680},{"date":"2022-03-25","current":-23.265801,"twenty":-15.804034,"median":-14.369858,"eighty":-12.515763,"marketCap":5694486160},{"date":"2022-04-01","current":-22.572946,"twenty":-18.160245,"median":-14.63199,"eighty":-12.7161,"marketCap":5531476060},{"date":"2022-04-08","current":-23.715707,"twenty":-21.833142,"median":-14.748151,"eighty":-12.739702,"marketCap":5814026900},{"date":"2022-04-14","current":-21.490504,"twenty":-21.683047,"median":-14.849995,"eighty":-12.849265,"marketCap":5259792560},{"date":"2022-04-22","current":-19.863698,"twenty":-21.600394,"median":-14.955439,"eighty":-12.933785,"marketCap":4770762260},{"date":"2022-04-29","current":-19.590787,"twenty":-21.409116,"median":-15.049314,"eighty":-13.002214,"marketCap":4629486840},{"date":"2022-05-06","current":-17.396263,"twenty":-21.270237,"median":-15.076137,"eighty":-13.110961,"marketCap":4076752500},{"date":"2022-05-13","current":-18.610663,"twenty":-21.20305,"median":-15.230713,"eighty":-13.274087,"marketCap":4283307960},{"date":"2022-05-20","current":-18.632644,"twenty":-20.958324,"median":-15.665764,"eighty":-13.314768,"marketCap":4348536000},{"date":"2022-05-27","current":-17.623136,"twenty":-20.880127,"median":-16.522446,"eighty":-13.630838,"marketCap":4109366520},{"date":"2022-06-02","current":-17.853668,"twenty":-20.492571,"median":-17.233543,"eighty":-13.641012,"marketCap":4185465900},{"date":"2022-06-10","current":-18.161257,"twenty":-19.970095,"median":-17.41371,"eighty":-13.669209,"marketCap":4228951260},{"date":"2022-06-17","current":-17.854023,"twenty":-19.645369,"median":-17.431157,"eighty":-13.717329,"marketCap":4152851880},{"date":"2022-06-24","current":-18.109092,"twenty":-19.371762,"median":-17.63025,"eighty":-13.745249,"marketCap":4228951260},{"date":"2022-06-30","current":-17.673991,"twenty":-19.310985,"median":-17.653236,"eighty":-13.764675,"marketCap":4120237860},{"date":"2022-07-08","current":-18.30801,"twenty":-19.310985,"median":-17.673991,"eighty":-13.849281,"marketCap":4272436620},{"date":"2022-07-15","current":-16.316301,"twenty":-19.289141,"median":-17.666899,"eighty":-13.997737,"marketCap":3772354980},{"date":"2022-07-22","current":-16.540555,"twenty":-19.000023,"median":-17.637365,"eighty":-14.143712,"marketCap":3826711680},{"date":"2022-07-29","current":-15.769476,"twenty":-18.747643,"median":-17.569111,"eighty":-14.282271,"marketCap":3652770240},{"date":"2022-08-05","current":-16.327325,"twenty":-18.677534,"median":-17.396263,"eighty":-14.357524,"marketCap":3772354980},{"date":"2022-08-12","current":-16.540049,"twenty":-18.643914,"median":-17.288694,"eighty":-14.388894,"marketCap":3826711680},{"date":"2022-08-19","current":-16.280106,"twenty":-18.622948,"median":-17.233543,"eighty":-14.502281,"marketCap":3728869620},{"date":"2022-08-26","current":-18.968898,"twenty":-18.789197,"median":-17.288694,"eighty":-14.644506,"marketCap":3815840340},{"date":"2022-09-02","current":-16.867763,"twenty":-18.730307,"median":-17.347726,"eighty":-14.697577,"marketCap":3380986740},{"date":"2022-09-09","current":-16.76889,"twenty":-18.677534,"median":-17.249775,"eighty":-14.757865,"marketCap":3348372720},{"date":"2022-09-16","current":-15.716335,"twenty":-18.64955,"median":-17.115151,"eighty":-14.796788,"marketCap":3109203240},{"date":"2022-09-23","current":-15.015443,"twenty":-18.62618,"median":-16.946014,"eighty":-14.839374,"marketCap":2913519120},{"date":"2022-09-30","current":-15.37826,"twenty":-18.614156,"median":-16.751565,"eighty":-14.921103,"marketCap":2989618500},{"date":"2022-10-07","current":-14.819903,"twenty":-18.606636,"median":-16.630085,"eighty":-14.836542,"marketCap":2880905100},{"date":"2022-10-14","current":-13.000449,"twenty":-18.587919,"median":-16.540555,"eighty":-14.695572,"marketCap":2500408200},{"date":"2022-10-21","current":-13.203919,"twenty":-18.5546,"median":-16.521647,"eighty":-14.34519,"marketCap":2522150880},{"date":"2022-10-28","current":-14.480815,"twenty":-18.46151,"median":-16.451964,"eighty":-14.220761,"marketCap":2761320360},{"date":"2022-11-04","current":-17.728963,"twenty":-18.445575,"median":-16.484507,"eighty":-14.220761,"marketCap":3413600760},{"date":"2022-11-11","current":-16.285217,"twenty":-18.404401,"median":-16.520848,"eighty":-14.319989,"marketCap":3163559940},{"date":"2022-11-18","current":-20.103605,"twenty":-18.5546,"median":-16.540302,"eighty":-14.34519,"marketCap":3891939720},{"date":"2022-11-25","current":-17.886989,"twenty":-18.5546,"median":-16.584302,"eighty":-14.376203,"marketCap":3435343440},{"date":"2022-12-02","current":-19.030264,"twenty":-18.606636,"median":-16.684302,"eighty":-14.417431,"marketCap":3717998280},{"date":"2022-12-09","current":-19.130787,"twenty":-18.629412,"median":-16.76889,"eighty":-14.498534,"marketCap":3772354980},{"date":"2022-12-16","current":-20.667558,"twenty":-18.761338,"median":-16.964223,"eighty":-14.594443,"marketCap":4065881160},{"date":"2022-12-23","current":-24.859641,"twenty":-18.956709,"median":-17.233543,"eighty":-14.695572,"marketCap":4892103000},{"date":"2022-12-30","current":-25.871174,"twenty":-19.083574,"median":-17.249775,"eighty":-14.69858,"marketCap":5153015160},{"date":"2023-01-06","current":-25.12186,"twenty":-19.140053,"median":-17.290439,"eighty":-14.757865,"marketCap":5055173100},{"date":"2023-01-13","current":-24.544401,"twenty":-19.323084,"median":-17.396263,"eighty":-14.796822,"marketCap":5033430420},{"date":"2023-01-20","current":-23.420078,"twenty":-19.652908,"median":-17.543878,"eighty":-14.810698,"marketCap":4761646920},{"date":"2023-01-27","current":-23.468747,"twenty":-19.824386,"median":-17.569111,"eighty":-14.819903,"marketCap":4772518260},{"date":"2023-02-03","current":-24.305158,"twenty":-20.244661,"median":-17.636045,"eighty":-14.865105,"marketCap":4968202380},{"date":"2023-02-10","current":-21.134736,"twenty":-20.667558,"median":-17.653236,"eighty":-14.903098,"marketCap":4294179300},{"date":"2023-02-17","current":-19.716053,"twenty":-20.880127,"median":-17.673991,"eighty":-14.948111,"marketCap":3968039100},{"date":"2023-02-24","current":-17.499248,"twenty":-20.667558,"median":-17.683976,"eighty":-14.962767,"marketCap":3478828800},{"date":"2023-03-03","current":-17.930481,"twenty":-20.549416,"median":-17.681738,"eighty":-14.98647,"marketCap":3587542200},{"date":"2023-03-10","current":-16.312167,"twenty":-16.61243,"median":-16.354707,"eighty":-16.246481,"marketCap":3239659320},{"date":"2023-03-17","current":-15.99321,"twenty":-859.547185,"median":-27.214831,"eighty":-15.236448,"marketCap":3207045300},{"date":"2023-03-24","current":-8.158391,"twenty":-857.733696,"median":-27.194813,"eighty":-15.146534,"marketCap":2957004480},{"date":"2023-03-31","current":-7.55624,"twenty":-856.818296,"median":-27.138398,"eighty":-15.059097,"marketCap":2717835000},{"date":"2023-04-06","current":-7.893805,"twenty":-856.073051,"median":-27.078657,"eighty":-15.049314,"marketCap":2837419740},{"date":"2023-04-14","current":-8.61117,"twenty":-855.930861,"median":-27.005778,"eighty":-15.016535,"marketCap":3098331900},{"date":"2023-04-21","current":-7.829618,"twenty":-853.743672,"median":-26.946633,"eighty":-14.959836,"marketCap":2815677060},{"date":"2023-04-28","current":-7.736069,"twenty":-851.842458,"median":-26.911578,"eighty":-14.890978,"marketCap":2761320360},{"date":"2023-05-05","current":-8.453174,"twenty":-850.368239,"median":-26.887993,"eighty":-14.810698,"marketCap":3022232520},{"date":"2023-05-12","current":-7.654484,"twenty":-844.255875,"median":-26.864581,"eighty":-14.748851,"marketCap":2717835000},{"date":"2023-05-19","current":-7.204671,"twenty":-840.637331,"median":-26.809281,"eighty":-14.567812,"marketCap":2522150880},{"date":"2023-05-25","current":-7.047343,"twenty":-839.945996,"median":-26.786513,"eighty":-14.442753,"marketCap":2456922840},{"date":"2023-06-02","current":-5.913628,"twenty":-835.38621,"median":-26.758553,"eighty":-14.376203,"marketCap":2054683260},{"date":"2023-06-09","current":-5.702832,"twenty":-818.129553,"median":-26.710974,"eighty":-14.315719,"marketCap":1978583880},{"date":"2023-06-16","current":-6.044208,"twenty":-802.117148,"median":-26.699006,"eighty":-14.193526,"marketCap":2086980480},{"date":"2023-06-23","current":-5.845382,"twenty":-785.68443,"median":-26.663692,"eighty":-13.898995,"marketCap":2007320300},{"date":"2023-06-30","current":-5.980535,"twenty":-778.272292,"median":-26.61418,"eighty":-13.87645,"marketCap":2035154520},{"date":"2023-07-07","current":-6.605364,"twenty":-429.563707,"median":-26.606395,"eighty":-13.753995,"marketCap":2243396480},{"date":"2023-07-14","current":-6.997294,"twenty":-301.659425,"median":-26.583832,"eighty":-13.673153,"marketCap":2409856960},{"date":"2023-07-21","current":-6.759426,"twenty":-288.581382,"median":-26.525876,"eighty":-13.629373,"marketCap":2317116240},{"date":"2023-07-28","current":-6.234106,"twenty":-276.345263,"median":-26.501017,"eighty":-13.418778,"marketCap":2134750610},{"date":"2023-08-04","current":-5.879734,"twenty":-267.511133,"median":-26.433729,"eighty":-13.322151,"marketCap":2016749320},{"date":"2023-08-11","current":-5.535688,"twenty":-209.927243,"median":-26.317959,"eighty":-13.137257,"marketCap":1888020640},{"date":"2023-08-18","current":-5.702326,"twenty":-206.412816,"median":-26.285946,"eighty":-13.008751,"marketCap":1930930200},{"date":"2023-08-25","current":-8.437208,"twenty":-153.130438,"median":-26.194028,"eighty":-12.926079,"marketCap":2209842340},{"date":"2023-09-01","current":-8.966812,"twenty":-53.382403,"median":-26.066754,"eighty":-12.827356,"marketCap":2358305400},{"date":"2023-09-08","current":-8.927792,"twenty":-49.491615,"median":-25.991719,"eighty":-12.748779,"marketCap":2320400530},{"date":"2023-09-15","current":-7.693984,"twenty":-47.216764,"median":-25.915129,"eighty":-12.699259,"marketCap":2015229510},{"date":"2023-09-22","current":-7.514168,"twenty":-46.322006,"median":-25.798974,"eighty":-12.601365,"marketCap":1959526400},{"date":"2023-09-29","current":-8.005269,"twenty":-45.602151,"median":-25.742295,"eighty":-12.513573,"marketCap":2091174700},{"date":"2023-10-06","current":-7.794811,"twenty":-44.867875,"median":-25.623114,"eighty":-12.464811,"marketCap":2035223040},{"date":"2023-10-13","current":-7.593854,"twenty":-44.174678,"median":-25.459845,"eighty":-12.377739,"marketCap":1979791440},{"date":"2023-10-20","current":-7.173699,"twenty":-43.742069,"median":-24.944313,"eighty":-12.316404,"marketCap":1867371240},{"date":"2023-10-27","current":-7.332259,"twenty":-43.600883,"median":-24.544401,"eighty":-12.227731,"marketCap":1907826880},{"date":"2023-11-03","current":-7.467694,"twenty":-43.226685,"median":-24.305158,"eighty":-11.9436,"marketCap":1948225750},{"date":"2023-11-10","current":-7.539507,"twenty":-42.611945,"median":-23.686985,"eighty":-11.104028,"marketCap":1966549970},{"date":"2023-11-17","current":-7.348049,"twenty":-42.179625,"median":-23.417707,"eighty":-10.369722,"marketCap":1933897040},{"date":"2023-11-24","current":-7.63362,"twenty":-41.40647,"median":-22.798937,"eighty":-10.175003,"marketCap":2025594830},{"date":"2023-12-01","current":-7.277958,"twenty":-40.622269,"median":-22.111475,"eighty":-10.082303,"marketCap":1939227350},{"date":"2023-12-08","current":-6.705384,"twenty":-39.890302,"median":-21.490504,"eighty":-9.976804,"marketCap":1779442700},{"date":"2023-12-15","current":-6.541665,"twenty":-39.34123,"median":-20.977411,"eighty":-9.850148,"marketCap":1746020070},{"date":"2023-12-22","current":-6.098485,"twenty":-38.040839,"median":-20.549416,"eighty":-9.736195,"marketCap":1626644760},{"date":"2023-12-29","current":-5.677286,"twenty":-37.684082,"median":-20.244661,"eighty":-9.647662,"marketCap":1522372660},{"date":"2024-01-05","current":-5.003084,"twenty":-37.205408,"median":-19.863698,"eighty":-9.579458,"marketCap":1332122880},{"date":"2024-01-12","current":-5.31345,"twenty":-36.743617,"median":-19.590787,"eighty":-9.495308,"marketCap":1415514140},{"date":"2024-01-19","current":-5.871801,"twenty":-36.390552,"median":-19.317006,"eighty":-9.4536,"marketCap":1562111600},{"date":"2024-01-26","current":-6.568447,"twenty":-36.077009,"median":-19.153952,"eighty":-9.378434,"marketCap":1740643600},{"date":"2024-02-02","current":-6.549533,"twenty":-35.939845,"median":-19.030264,"eighty":-9.332778,"marketCap":1733418600},{"date":"2024-02-09","current":-6.6813,"twenty":-35.587972,"median":-18.817772,"eighty":-9.258152,"marketCap":1777000750},{"date":"2024-02-16","current":-7.015472,"twenty":-35.201054,"median":-18.681712,"eighty":-9.243388,"marketCap":1866282560},{"date":"2024-02-23","current":-6.965496,"twenty":-34.904271,"median":-18.584004,"eighty":-9.15982,"marketCap":1843219560},{"date":"2024-03-01","current":-6.578674,"twenty":-34.762406,"median":-18.393775,"eighty":-9.048962,"marketCap":1741943760},{"date":"2024-03-08","current":-6.116976,"twenty":-34.291324,"median":-18.358603,"eighty":-8.989107,"marketCap":1620412800},{"date":"2024-03-15","current":-6.31372,"twenty":-34.169695,"median":-18.286774,"eighty":-8.966068,"marketCap":1671050700},{"date":"2024-03-22","current":-6.0897,"twenty":-34.007358,"median":-18.165862,"eighty":-8.908417,"marketCap":1610285220},{"date":"2024-03-28","current":-9.241453,"twenty":-33.918806,"median":-18.128877,"eighty":-8.893205,"marketCap":1448243940},{"date":"2024-04-05","current":-8.536193,"twenty":-33.589784,"median":-18.065512,"eighty":-8.838523,"marketCap":1336840560},{"date":"2024-04-12","current":-8.272823,"twenty":-33.35649,"median":-17.939408,"eighty":-8.727145,"marketCap":1296330240},{"date":"2024-04-19","current":-8.279892,"twenty":-33.174366,"median":-17.853668,"eighty":-8.605272,"marketCap":1296330240},{"date":"2024-04-26","current":-8.678713,"twenty":-33.059884,"median":-17.759229,"eighty":-8.524743,"marketCap":1357095720},{"date":"2024-05-03","current":-9.203206,"twenty":-32.801614,"median":-17.687796,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-10","current":-9.181408,"twenty":-32.632919,"median":-17.661614,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-17","current":-8.741635,"twenty":-32.551122,"median":-17.623136,"eighty":-8.477563,"marketCap":1367223300},{"date":"2024-05-24","current":-8.177535,"twenty":-32.325579,"median":-17.539325,"eighty":-8.449981,"marketCap":1276075080},{"date":"2024-05-31","current":-7.845046,"twenty":-32.033995,"median":-17.347726,"eighty":-8.385666,"marketCap":1225437180},{"date":"2024-06-07","current":-7.400377,"twenty":-31.809988,"median":-17.233543,"eighty":-8.298959,"marketCap":1154544120},{"date":"2024-06-14","current":-6.887364,"twenty":-31.578107,"median":-16.935206,"eighty":-8.273349,"marketCap":1073523480},{"date":"2024-06-21","current":-5.860029,"twenty":-31.347447,"median":-16.734241,"eighty":-8.218166,"marketCap":911482200},{"date":"2024-06-28","current":-5.211077,"twenty":-31.228256,"median":-16.576517,"eighty":-8.179208,"marketCap":810206400},{"date":"2024-07-05","current":-6.059193,"twenty":-31.009798,"median":-16.520848,"eighty":-8.127037,"marketCap":941864940},{"date":"2024-07-12","current":-6.115326,"twenty":-30.76933,"median":-16.436478,"eighty":-8.062904,"marketCap":951986880},{"date":"2024-07-19","current":-7.004141,"twenty":-30.557099,"median":-16.340035,"eighty":-8.028781,"marketCap":1090371240},{"date":"2024-07-26","current":-7.669327,"twenty":-30.166665,"median":-16.305518,"eighty":-7.995559,"marketCap":1198359750},{"date":"2024-08-02","current":-6.796557,"twenty":-29.911296,"median":-16.197141,"eighty":-7.891041,"marketCap":1061367400},{"date":"2024-08-09","current":-5.605068,"twenty":-29.68082,"median":-16.109649,"eighty":-7.860985,"marketCap":881135200},{"date":"2024-08-16","current":-5.284545,"twenty":-29.399025,"median":-16.004915,"eighty":-7.841452,"marketCap":831070700},{"date":"2024-08-23","current":-4.945296,"twenty":-29.313204,"median":-15.849402,"eighty":-7.79201,"marketCap":781006200},{"date":"2024-08-30","current":-5.353167,"twenty":-29.110493,"median":-15.769476,"eighty":-7.728882,"marketCap":851096500},{"date":"2024-09-06","current":-3.418622,"twenty":-28.890701,"median":-15.662682,"eighty":-7.666358,"marketCap":971251300},{"date":"2024-09-13","current":-3.060869,"twenty":-28.749884,"median":-15.561249,"eighty":-7.617596,"marketCap":867335190},{"date":"2024-09-20","current":-3.483773,"twenty":-28.561104,"median":-15.420271,"eighty":-7.598347,"marketCap":993090000},{"date":"2024-09-27","current":-3.760093,"twenty":-28.333146,"median":-15.365842,"eighty":-7.561653,"marketCap":1078304300},{"date":"2024-10-04","current":-4.747552,"twenty":-28.250282,"median":-15.319205,"eighty":-7.535461,"marketCap":1355299900},{"date":"2024-10-10","current":-4.708735,"twenty":-28.130154,"median":-15.28172,"eighty":-7.522101,"marketCap":1335514500},{"date":"2024-10-18","current":-4.628229,"twenty":-28.007466,"median":-15.211834,"eighty":-7.460943,"marketCap":1305836400},{"date":"2024-10-25","current":-4.787628,"twenty":-27.863809,"median":-15.071389,"eighty":-7.420411,"marketCap":1350724680},{"date":"2024-11-01","current":-4.888412,"twenty":-27.732043,"median":-15.043947,"eighty":-7.390073,"marketCap":1380088260},{"date":"2024-11-08","current":-5.393498,"twenty":-27.592224,"median":-14.969216,"eighty":-7.334181,"marketCap":1515776000},{"date":"2024-11-15","current":-5.694569,"twenty":-27.430791,"median":-14.889359,"eighty":-7.267767,"marketCap":1583441460},{"date":"2024-11-22","current":-6.224792,"twenty":-27.252497,"median":-14.784149,"eighty":-7.20416,"marketCap":1730056410},{"date":"2024-11-29","current":-5.401652,"twenty":-27.149392,"median":-14.63199,"eighty":-7.145452,"marketCap":1500274450},{"date":"2024-12-06","current":-6.462356,"twenty":-26.958966,"median":-14.415446,"eighty":-7.084264,"marketCap":1790650150},{"date":"2024-12-13","current":-7.525158,"twenty":-26.898699,"median":-14.328346,"eighty":-7.042598,"marketCap":2081025850},{"date":"2024-12-20","current":-9.773511,"twenty":-26.831826,"median":-14.194883,"eighty":-7.042598,"marketCap":2690814820},{"date":"2024-12-27","current":-10.308856,"twenty":-26.785545,"median":-13.98128,"eighty":-7.042598,"marketCap":2836002670},{"date":"2025-01-03","current":-11.036911,"twenty":-26.724476,"median":-13.876142,"eighty":-7.042598,"marketCap":3039265660},{"date":"2025-01-10","current":-10.090962,"twenty":-26.659448,"median":-13.738689,"eighty":-7.042598,"marketCap":2768248340},{"date":"2025-01-17","current":-13.505837,"twenty":-26.604626,"median":-13.644863,"eighty":-7.042598,"marketCap":3708038950},{"date":"2025-01-24","current":-14.258417,"twenty":-26.513964,"median":-13.644863,"eighty":-7.042598,"marketCap":3939189430},{"date":"2025-01-28","current":-14.045364,"twenty":-26.50266,"median":-13.646172,"eighty":-7.044971,"marketCap":3900664350},{"date":"2025-02-07","current":-14.613563,"twenty":-26.385453,"median":-13.643555,"eighty":-7.040226,"marketCap":4035502130},{"date":"2025-02-14","current":-14.027409,"twenty":-26.305488,"median":-13.643555,"eighty":-7.040226,"marketCap":3871770540},{"date":"2025-02-21","current":-20.966333,"twenty":-26.268748,"median":-13.643555,"eighty":-7.040226,"marketCap":5807655810},{"date":"2025-02-28","current":-23.024105,"twenty":-26.124527,"median":-13.643555,"eighty":-7.040226,"marketCap":6356638200},{"date":"2025-03-07","current":-23.948261,"twenty":-26.021583,"median":-13.637196,"eighty":-7.037853,"marketCap":6638331300},{"date":"2025-03-14","current":-27.478442,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7619649840},{"date":"2025-03-21","current":-28.63462,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7937135250},{"date":"2025-03-28","current":-22.254415,"twenty":-25.981622,"median":-13.637196,"eighty":-7.037853,"marketCap":7167473650},{"date":"2025-04-03","current":-19.455031,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"marketCap":6253500500},{"date":"2025-04-11","current":-16.143826,"twenty":-25.799935,"median":-13.637196,"eighty":-7.037853,"marketCap":5154695920},{"date":"2025-04-17","current":-14.844692,"twenty":-25.761244,"median":-13.643555,"eighty":-7.040226,"marketCap":4751255705},{"date":"2025-04-25","current":-18.855479,"twenty":-25.629177,"median":-13.630838,"eighty":-7.035481,"marketCap":6040177180},{"date":"2025-05-02","current":-19.624433,"twenty":-25.555188,"median":-13.637196,"eighty":-7.037853,"marketCap":6299866327},{"date":"2025-05-09","current":-19.687295,"twenty":-25.378575,"median":-13.630838,"eighty":-7.035481,"marketCap":6364413943},{"date":"2025-05-16","current":-16.189425,"twenty":-25.028984,"median":-13.630838,"eighty":-7.035481,"marketCap":5276397641},{"date":"2025-05-23","current":-19.381154,"twenty":-24.642413,"median":-13.630838,"eighty":-7.035481,"marketCap":6335528555},{"date":"2025-05-30","current":-22.492822,"twenty":-24.315979,"median":-13.630838,"eighty":-7.035481,"marketCap":7385031005},{"date":"2025-06-06","current":-22.37708,"twenty":-24.163622,"median":-13.630838,"eighty":-7.035481,"marketCap":7365774080},{"date":"2025-06-13","current":-27.602111,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9089268930},{"date":"2025-06-20","current":-28.183664,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9262581261},{"date":"2025-06-27","current":-25.15423,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8290106513},{"date":"2025-07-04","current":-27.519363,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9070012004},{"date":"2025-07-11","current":-25.909492,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8530818085},{"date":"2025-07-18","current":-34.00727,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11188273831},{"date":"2025-07-25","current":-31.259636,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10321712175},{"date":"2025-08-01","current":-30.808479,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10109885992},{"date":"2025-08-08","current":-40.038892,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13171737178},{"date":"2025-08-15","current":-51.999696,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17080893095},{"date":"2025-08-22","current":-50.820081,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14298267332},{"date":"2025-08-29","current":-48.026994,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13576938778},{"date":"2025-09-05","current":-47.125793,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13308972881},{"date":"2025-09-12","current":-39.078151,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11056074414},{"date":"2025-09-19","current":-37.494834,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10600591060},{"date":"2025-09-26","current":-36.39561,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10263119060},{"date":"2025-10-03","current":-37.842129,"twenty":-24.207039,"median":-13.643555,"eighty":-7.040226,"marketCap":10696487426},{"date":"2025-10-10","current":-33.495493,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9454067526},{"date":"2025-10-17","current":-32.00426,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9026136568},{"date":"2025-10-24","current":-32.086576,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9052642598},{"date":"2025-10-31","current":-33.892495,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9576412188},{"date":"2025-11-07","current":-33.200765,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9375102324},{"date":"2025-11-14","current":-48.131606,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13629727156},{"date":"2025-11-21","current":-46.471802,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13153579483},{"date":"2025-11-28","current":-51.08762,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14512584301},{"date":"2025-12-05","current":-47.583674,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13540449468},{"date":"2025-12-12","current":-50.523029,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14403467126},{"date":"2025-12-19","current":-45.12776,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12895666160},{"date":"2025-12-24","current":-43.638002,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12508796175},{"date":"2026-01-02","current":-39.705675,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":11426392166},{"date":"2026-01-09","current":-43.068244,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":12424923948},{"date":"2026-01-16","current":-45.622443,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":13204565721},{"date":"2026-01-23","current":-48.737975,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":14092765209},{"date":"2026-01-30","current":-46.885388,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":13619058816},{"date":"2026-02-06","current":-51.771469,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":15076489664}],"updateTime":1770636433064},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01672\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148180037","title":"HK Movers | Ascletis Pharma Stock up 8% After GIC Invests US$100M in Company, Anchoring Long-Term Capital in China's Core Innovative Drug Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1148180037","media":"Tiger Newspress","labels":["shareholding","movement"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1148180037?lang=en_us&edition=fundamental","pubTime":"2026-02-09 10:12","pubTimestamp":1770603160,"startTime":"0","endTime":"0","summary":"According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC) has acquired an initial stake in Ascletis Pharma (1672....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"HK Movers | Ascletis Pharma Stock up 8% After GIC Invests US$100M in Company, Anchoring Long-Term...","news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"1159339612","title":"ASCLETIS-B Shares Surge Nearly 9% in Morning Session Following GIC's HK$781 Million Stake Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1159339612","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159339612?lang=en_us&edition=fundamental","pubTime":"2026-02-09 09:46","pubTimestamp":1770601588,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) rose nearly 9% during the morning trading session. At the time of writing, the stock was up 8.29%, trading at HK$16.46, with a turnover of HK$14.289 million. The price movement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","01672","VT","BK4588","BK1191","BK1515","01477","BK1574","GIC","VXUS","BK4585","BK1161"],"gpt_icon":0},{"id":"1197290640","title":"Tirzepatide Crowned as New \"Blockbuster Drug King\" with Rapid Commercial Value Release Expected for Weight Loss Medications","url":"https://stock-news.laohu8.com/highlight/detail?id=1197290640","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197290640?lang=en_us&edition=fundamental","pubTime":"2026-02-05 13:54","pubTimestamp":1770270882,"startTime":"0","endTime":"0","summary":"Orient Securities has released a research report stating that, according to Eli Lilly's disclosed 2025 performance, Tirzepatide achieved annual sales of $36.507 billion, representing a 122% increase....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU1951186391.HKD","IE00B543WZ88.USD","LU1813983027.USD","LU0140636845.USD","IE0008369823.USD","BK1147","IE00BZ08YR35.GBP","BK1515","BK0012","HK0000165453.HKD","LU1960683339.HKD","LU1226287875.USD","BK0276","IE00BZ08YT58.USD","600958","IE00BZ08YS42.EUR","LU0880133367.SGD","LU1226288170.HKD","LU0067412154.USD","LU0501845795.SGD","LU1328277881.USD","LU1226287529.USD","BK0188","LU1226288253.USD","LU1993786604.SGD","LU1008478684.HKD","03958","IE00B5MMRT66.SGD","LU0314109678.HKD","BK1161","LU1807302812.USD","LU0315179316.USD","LU0326950275.SGD","LU1226287792.SGD","BK0183","BK1521","LU0072913022.USD","01093","01672","BK1191","BK1574","LU1152091754.HKD","IE0008368742.USD","LU1152091168.USD","SG9999004220.SGD","BK0028","LU2039709279.SGD","BK1564"],"gpt_icon":0},{"id":"2608594395","title":"Ascletis Pharma (SEHK:1672) Is Up 5.4% After HK$844m Follow-On Offering And Positive Phase III Acne Data - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608594395","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608594395?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:31","pubTimestamp":1770215473,"startTime":"0","endTime":"0","summary":"Ascletis Pharma recently filed a follow-on equity offering of HK$843.54 million via a subsequent direct listing, issuing 69,256,000 ordinary shares at HK$12.18 each.\nThe fundraising follows positive Phase III data for denifanstat in moderate-to-severe acne and progress with ASC30 in metabolic disease, underscoring Ascletis’s late-stage pipeline momentum.\nWe’ll now explore how this combination of positive Phase III acne data and a sizable equity raise shapes Ascletis Pharma’s investment...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-is-up-54-after-hk844m-follow-on-off","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-is-up-54-after-hk844m-follow-on-off","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","BK4134","III","01672","BK1515"],"gpt_icon":0},{"id":"2608807643","title":"After Clearing Up Acne, Sagimet Stock Rises -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2608807643","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608807643?lang=en_us&edition=fundamental","pubTime":"2026-02-04 04:27","pubTimestamp":1770150420,"startTime":"0","endTime":"0","summary":"Shares of Sagimet Biosciences were up as much as 12% Tuesday morning, on encouraging clinical trial results for its acne treatment and a new Buy recommendation from Guggenheim Securities.For much of its history, the San Mateo, Calif-based firm played up the promise of its novel drug for treating liver diseases brought on by obesity. But lately, it is drawing attention for those drugs' success at clearing a more familiar affliction: acne.The news helped lift Sagimet stock Tuesday to $7.20 and bring the little company's market cap to $230 million. That is well below the $16 level where Sagimet came public in 2023. But in a Tuesday note launching coverage on the company, Guggenheim's Seamus Fernandez says the stock can rise as high as $27, if either the liver or acne drug reach his expectations.If approved and launched by 2030, he thinks the drug's sales as a first line treatment for acne could surpass a billion dollars. The existing treatments include generic versions of the Roche drug A","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4139","SGMT","01672","BK1515","BK1161"],"gpt_icon":0},{"id":"1136207146","title":"Ascletis (01672) Publishes Monthly Return on Securities Movements for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136207146","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136207146?lang=en_us&edition=fundamental","pubTime":"2026-02-03 19:25","pubTimestamp":1770117954,"startTime":"0","endTime":"0","summary":"On 3 February 2026, Ascletis Pharma Inc. (stock code: 01672) released its Monthly Return for Equity Issuer for the period ended 31 January 2026. The authorized share capital remained at 7,000,000,000...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"2608123118","title":"Ascletis Pharma Seeks HK$843 Million via Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2608123118","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608123118?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:20","pubTimestamp":1770081645,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it was looking to raise HK$843.5 million via a share offering, according to a Hong Kong bourse filing Tuesday.The firm is seeking investors for around 69.3 million shares priced at HK$12.18 apiece to raise funds for the global phase 3 trials of its ASC30 drug for the treatment of obesity.The shares represent 6.98% of the company's issued share capital.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","01672","BK1515","BK1161"],"gpt_icon":0},{"id":"2608812836","title":"BRIEF-Ascletis Pharma To Place 69.3 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2608812836","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608812836?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:19","pubTimestamp":1770081598,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Pharma To Place 69.3 Million SharesFeb 3 (Reuters) - Ascletis Pharma Inc 1672.HK:TO PLACE 69.3 MILLION SHARES AT HK$12.18 PER SHAREFurther company coverage: 1672.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YY0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"1194027137","title":"ASCLETIS-B (01672) Proposes Placement of 69.256 Million Shares at Approximately 4% Discount, Targeting Net Proceeds of About HK$835.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1194027137","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194027137?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:44","pubTimestamp":1770075857,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that on February 3, 2026, the company proposes to place 69.256 million shares, representing approximately 6.98% of the company's issued share capital as of the date of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","01477","BK1191","01672","BK1161"],"gpt_icon":0},{"id":"2608816721","title":"Ascletis Pharma kündigt Privatplatzierung neuer Aktien an","url":"https://stock-news.laohu8.com/highlight/detail?id=2608816721","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608816721?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:41","pubTimestamp":1770075710,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLNPmZt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1515","BK1574"],"gpt_icon":0},{"id":"2608164468","title":"Ascletis Pharma Inc -  to Place 69.3 Mln Shares at HK$12.18 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608164468","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608164468?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:31","pubTimestamp":1770075105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YY0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1515","01672"],"gpt_icon":0},{"id":"2608657558","title":"Sagimet Biosciences Reports Positive 52-Week Phase 3 Results for Denifanstat in Moderate to Severe Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2608657558","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608657558?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:00","pubTimestamp":1770033629,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc. announced positive 52-week data from an open-label Phase 3 clinical trial conducted by its license partner, Ascletis Pharma Inc., evaluating the long-term safety of ASC40  tablets in patients with moderate to severe acne. The topline results from this trial were reported in a press release issued by Ascletis on January 29. Denifanstat is an oral fatty acid synthase  inhibitor developed by Ascletis for acne in China and by Sagimet for MASH in other regions. In June 2025, Ascletis also reported that denifanstat met all primary, key secondary, and secondary endpoints in a separate 480-patient randomized, double-blind, placebo-controlled Phase 3 trial for moderate to severe acne vulgaris. Results from both studies have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLc00t16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","NDAQ","LU2210150020.SGD","BK4139","BK1515","LU0314104364.USD","SG9999014005.SGD","SG9999014021.USD","IE00BGHQF748.EUR","BK4112","BK1574","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","01672","SGMT","BK1161"],"gpt_icon":0},{"id":"2608837837","title":"Assessing Ascletis Pharma (SEHK:1672) Valuation After Positive Acne Data And Denifanstat NDA Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=2608837837","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608837837?lang=en_us&edition=fundamental","pubTime":"2026-02-02 10:11","pubTimestamp":1769998295,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) is back in focus after reporting favorable long term safety data from its Phase III acne drug denifanstat and confirming that China’s regulator has accepted its New Drug Application.\nSee our latest analysis for Ascletis Pharma.\nThe acne data and NDA progress come on the back of an active few weeks across its GLP 1 and metabolic pipeline. The share price has moved accordingly, with a 30 day share price return of 19.79% and 90 day share price return of 40.67%, adding...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-positive","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-positive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","BK1515","01672"],"gpt_icon":0},{"id":"2607386890","title":"BRIEF-Ascletis Pharma Gets Positive Topline Results From Phase III Open-Label Study Of Denifanstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2607386890","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607386890?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:46","pubTimestamp":1769694367,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Pharma Gets Positive Topline Results From Phase III Open-Label Study Of DenifanstatJan 29 (Reuters) - Ascletis Pharma Inc 1672.HK:POSITIVE TOPLINE RESULTS FROM PHASE III OPEN-LABEL STUDY OF DENIFANSTAT (ASC40)Further company coverage: 1672.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU04P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1515","01672"],"gpt_icon":0},{"id":"1151778806","title":"Ascletis Pharma Inc. (1672) Announces Positive Phase III Data on Denifanstat (ASC40) for Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1151778806","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151778806?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:05","pubTimestamp":1769684706,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. (1672) released topline results from a Phase III open-label trial (NCT06248008) evaluating denifanstat (ASC40) in 240 patients with moderate to severe acne vulgaris. The study,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"1105812294","title":"Ascletis Pharma-B (01672): First-in-Class Oral FASN Inhibitor Denifostat (ASC40) Achieves Positive Topline Results in Phase III Open-Label Acne Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1105812294","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105812294?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:00","pubTimestamp":1769684431,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) announced positive topline results from a Phase III open-label study (NCT06248008) of denifostat (ASC40), a first-in-class, once-daily oral small-molecule fatty acid...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","BK1161","BK1574","BK1191","01672","BK1515","BK4134","01477"],"gpt_icon":0},{"id":"2607858060","title":"Ascletis Announces Positive Topline Results From Its Phase Iii Open-Label Study of Denifanstat (Asc40), a First-in-Class, Once-Daily Oral Fasn Inhibitor for Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2607858060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607858060?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:00","pubTimestamp":1769684402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUAC0NCDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2607085809","title":"Ascletis Pharma Inc - Denifanstat (Asc40) Shows Favorable Safety in Phase Iii Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2607085809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607085809?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:00","pubTimestamp":1769684402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUAC0NCDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1515","01672"],"gpt_icon":0},{"id":"2607832600","title":"Ascletis Pharma New Drug Application for Denifanstat Accepted by China National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2607832600","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607832600?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:51","pubTimestamp":1769683870,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. announced that its New Drug Application  for denifanstat , a first-in-class, once-daily oral fatty acid synthase  inhibitor for the treatment of moderate-to-severe acne vulgaris, was recently accepted by the China National Medical Products Administration. The acceptance follows positive topline results from two Phase III studies, including a recently completed open-label multicenter study in China evaluating the long-term safety of denifanstat in 240 patients. Denifanstat  is licensed from Sagimet Biosciences Inc. for exclusive rights in Greater China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL1NxTbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","SGMT","BK4139","01672"],"gpt_icon":0},{"id":"2607708347","title":"Ascletis Pharma Inc - Positive Topline Results From Phase Iii Open-Label Study of Denifanstat (Asc40)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607708347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607708347?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:50","pubTimestamp":1769683851,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU04P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","01672","BK1161","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}